Cubist Systematic Strategies, LLC Lannett CO Inc Transaction History

Cubist Systematic Strategies, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.93 $30,062 - $56,464	-19,271 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.91 - $4.83 $178,580 - $296,407	-61,368 Reduced 76.1%	19,271 $58,000
Q2 2021 Aug 16, 2021	BUY	$4.17 - $5.74 $273,873 - $376,985	65,677 Added 438.96%	80,639 $377,000
Q1 2021 May 17, 2021	BUY	$5.28 - $9.64 $78,999 - $144,233	14,962 New	14,962 $79,000
Q3 2020 Nov 16, 2020	SELL	$4.9 - $7.12 $53,493 - $77,729	-10,917 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$6.43 - $9.86 $70,196 - $107,641	10,917 New	10,917 $79,000
Q4 2019 Feb 14, 2020	SELL	$8.49 - $12.81 $3.14 Million - $4.74 Million	-370,380 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.58 - $14.47 $1.53 Million - $3.96 Million	273,333 Added 281.65%	370,380 $4.15 Million
Q2 2019 Aug 14, 2019	SELL	$5.22 - $9.08 $143,393 - $249,427	-27,470 Reduced 22.06%	97,047 $588,000
Q1 2019 May 15, 2019	BUY	$5.35 - $9.82 $666,165 - $1.22 Million	124,517 New	124,517 $980,000
Q4 2018 Feb 14, 2019	SELL	$3.43 - $6.19 $389,939 - $703,710	-113,685 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.75 - $14.5 $539,528 - $1.65 Million	113,585 Added 113585.0%	113,685 $540,000
Q2 2018 Aug 14, 2018	SELL	$13.3 - $17.45 $91,384 - $119,898	-6,871 Reduced 98.57%	100 $1,000
Q1 2018 May 15, 2018	SELL	$14.7 - $24.95 $116,085 - $197,030	-7,897 Reduced 53.11%	6,971 $112,000
Q4 2017 Feb 14, 2018	SELL	$19.9 - $29.25 $459,172 - $674,914	-23,074 Reduced 60.81%	14,868 $345,000
Q3 2017 Nov 14, 2017	BUY	$15.1 - $19.25 $572,924 - $730,383	37,942	37,942 $700,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.